As per Market Research Future Analysis, the Global Central Venous Catheter Market was valued at 1.34 USD Billion in 2024 and is projected to reach 2.31 USD Billion by 2034, growing at a CAGR of 5.60% from 2025 to 2034. The market is driven by the rising prevalence of chronic diseases, increasing surgical procedures, and the aging population, which necessitates effective medical interventions. North America leads the market due to high chronic illness rates, followed by Europe and Asia-Pacific, where rapid growth is anticipated.
The Central Venous Catheter market is witnessing significant growth due to various factors.
Key players include Amecath, B. Braun Melsungen AG, Boston Scientific Corporation, AngioDynamics, Inc., and Coloplast.
Design: Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for Central Venous Catheter is being driven by a growing prevalence of chronic diseases. The increasing incidence of chronic illnesses, particularly cardiovascular and cancer diseases, is one of the main factors driving the widespread use of central venous catheters (CVCs) in contemporary healthcare. These catheters are essential to providing patients with these difficult conditions with effective and ongoing care. CVCs are vital for patients receiving long-term treatments because they make it easier to administer vital drugs, blood transfusions, and fluid therapy. The necessity of central venous catheters in providing accurate and ongoing medical interventions is becoming more and more apparent as the burden of chronic diseases rises, highlighting their importance in improving patient care and treatment outcomes in the face of difficult medical situations.
The increasing number of surgical procedures, particularly in oncology and critical care units, is driving up demand for central venous catheters (CVCs). In these settings, these catheters are essential for a variety of medical applications, helping with vital tasks like medicine delivery, blood transfusions, and fluid administration. The need for effective intravenous access grows as surgical procedures become more complex due to medical advancements. Because they can deliver vital medical interventions dependably and directly, central venous catheters are now considered indispensable for precisely and promptly delivering fluids and medications, which has a substantial positive impact on patient outcomes in critical care and oncological settings.
The proportion of the population over 60 will rise from 1 billion in 2020 to 1.4 billion in 2022. The number of individuals 60 years of age and above will double (to 2.1 billion) worldwide by 2050. It is anticipated that between 2020 and 2050, the number of people 80 years of age or older will triple, reaching 426 million. The increased prevalence of chronic diseases brought about by the aging of the population has resulted in a persistent need for central venous catheters for a range of medical procedures. Thus, driving the Central Venous Catheter market revenue.
The Central Venous Catheter market segmentation, based on Property includes Non-tunneled Catheters and Tunneled Catheters. The Non-tunneled Catheter segment dominated the market, accounting for 47% of market revenue (0.564 Billion). The increase in incisions and the growing awareness of the importance of using non-tunneled catheters during emergencies are fueling this segment's overall growth.
The Central Venous Catheter market segmentation, based on Property includes Non-Antimicrobial Catheters, Antimicrobial Catheters, and Others. The Antimicrobial Catheters segment dominated the market, accounting for 36% of market revenue. The market in this region is expanding as a result of a emphasis on preventing HAIs (Healthcare-Associated Infections).
The Central Venous Catheter market segmentation, based on Design includes Multi Lumen, Double Lumen, and Single Lumen. The Double Lumen segment dominated the market, accounting for 18% of market revenue. The overall market growth in this region is being stimulated by the rise in the number of ICU treatments for ARF (acute renal failure).
The Central Venous Catheter market segmentation, based on Compositions includes Polyurethane, Silicone, and Others. The Silicon segment dominated the market, accounting for 15% of market revenue. Worldwide, silicone catheters are the preferred option because of their long-term use as tunneled central venous catheters (CVCs) and flexibility.
Figure 1: Central Venous Catheter Market, by Composition, 2022 & 2032 (USD Billion)
Design: Secondary Research, Primary Research, MRFR Database and Analyst Review
Central Venous Catheter Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific, and Rest of the World. The North American Central Venous Catheter market area will dominate this market. This is due to the region's high rate of chronic illnesses like cancer and kidney problems, the presence of important figures, and the rise in the number of critically ill patients.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: CENTRAL VENOUS CATHETER MARKET SHARE BY REGION 2022 (USD Billion)
Design: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Central Venous Catheter market accounts for the second-largest market share. A market is driven by an aging population’s increasing demand for advanced medical interventions, including CVCs for diseases such as cancer, heart diseases, and chronic conditions. Further, the German Central Venous Catheter market held the largest market share, and the UK Central Venous Catheter market was the fastest-growing market in the European region
The Asia-Pacific Central Venous Catheter Market is expected to grow at the fastest CAGR from 2025 to 2034. The major factors propelling the market's growth in the region are the high prevalence of chronic diseases, the rise in affordability, and the expansion of healthcare access in developing nations. Moreover, China’s Central Venous Catheter market held the largest market share, and the Indian Central Venous Catheter market was the fastest growing market in the Asia-Pacific region.
Central Venous Catheter Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the Central Venous Catheter market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Central Venous Catheter industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Central Venous Catheter industry to benefit clients and increase the market sector. In recent years, the Central Venous Catheter industry has offered some of the most significant advantages to Consumers. Major players in the Central Venous Catheter market, including Amecath, B. Braun Melsungen AG, Boston Scientific Corporation, AngioDynamics, Inc., BACTIGUARD, and others, are attempting to increase market demand by investing in product development to increase their product line and cater to diverse consumer needs.
One of the top healthcare companies that specializes in medical devices is Coloplast. The company is dedicated to enhancing patients' lives and focuses on providing cutting-edge solutions for personal healthcare requirements. Coloplast provides Central Venous Catheters (CVCs), which are essential for intravenous therapies, in the field of vascular access. These catheters are made with cutting-edge materials and technologies that guarantee patient safety and comfort while meeting the demanding needs of medical professionals. Coloplast's commitment to quality and patient care solidifies its standing as a reliable supplier in the medical field. January 2023, In the US, Coloplast unveiled a novel catheter. The SpeediCath Flex Set catheter is intended for those who have problems with their bladder and urine. Triple Action Coating Technology, available on all SpeediCath catheters, is designed to reduce the risk of urinary tract infections (UTIs) and urethral injury in individuals with spinal cord injuries (SCI).
One well-known healthcare organization that specializes in medical solutions is B. Braun Medical Inc. The company is well-known for its dedication to innovation and patient welfare, and it is a leader in pharmaceutical and medical device manufacturing. The Central Venous Catheter, an essential medical device for intravenous therapy, is at the heart of its product line. In the healthcare sector, B. Braun Medical Inc. is a reputable brand that is committed to developing medical technology and enhancing patient care everywhere. B. Braun Medical Inc. (B. Braun), a leader in infusion therapy, announced that its new Introcan Safety 2 IV Catheter with one-time blood control accessible by July 2022. The Introcan Safety 2 IV Catheter, the newest invention from B. Braun, reduces the risk of needlestick injuries and blood exposure for the clinician, making IV access safer.
Key Companies in the Central Venous Catheter market include
| Report Attribute/Metric | Details |
| Market Size 2024 | 1.34 (USD Billion) |
| Market Size 2025 | 1.41 (USD Billion) |
| Market Size 2034 | 2.31 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 5.60 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product Type, Property, Design, Composition, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Amecath, B. Braun Melsungen AG, Boston Scientific Corporation, AngioDynamics, Inc., BACTIGUARD, Cook Medical, Inc., Smiths Medical, Becton, Dickinson & Company, Biosensors International Group Ltd., BARD Care, ConMed Corporation, Edwards Lifesciences Corporation, and Coloplast. |
| Key Market Opportunities | Ongoing advancements in catheter technologies, materials, and designs enhance safety, efficacy, and patient comfort, driving market adoption. |
| Key Market Dynamics | Rising Awareness and Education that support for the market growth of Central Venous Catheter options. |
Frequently Asked Questions (FAQ):
The Central Venous Catheter market size was valued at USD 1.2 Billion in 2022.
The market is projected to grow at a CAGR of 5.60% during the forecast period, 2025-2034.
North America had the largest share in the market
The key players in the market are Amecath, B. Braun Melsungen AG, Boston Scientific Corporation, AngioDynamics, Inc., BACTIGUARD, Cook Medical, Inc., Smiths Medical, Becton, Dickinson & Company, and Biosensors International Group Ltd..
The Tunneled Catheters category dominated the market in 2022.
The Silicon had the largest share in the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
